Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × durvalumab × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 47 Triple Negative Breast Neoplasms 25 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Melanoma 8 Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Carcinoma, Merkel Cell 3 Lung Neoplasms 2 Kidney Neoplasms 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Thyroid Neoplasms 1

Interventions

Cyclophosphamide 38 Paclitaxel 22 Epirubicin 21 Trastuzumab 20 Docetaxel 20 Doxorubicin 19 Carboplatin 15 Radiotherapy 13 Taxes 11 Filgrastim 11 Neoadjuvant Therapy 9 Bevacizumab 9 Fluorouracil 8 pembrolizumab 7 Tamoxifen 7 Albumin-Bound Paclitaxel 7 Capecitabine 6 pertuzumab 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Lapatinib 5 130-nm albumin-bound paclitaxel 5 pegfilgrastim 4 Granulocyte Colony-Stimulating Factor 4 Cisplatin 4 Chemotherapy, Adjuvant 4 Biopsy 4 tipifarnib 3 eribulin 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05795101 2025-09-19

TRUDI

Dana-Farber Cancer Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡